Indefinite Delivery Contract SPE2DR25D3020

The federal contract IDV award is a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award IDC, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp for a base period of 30 months and three 30-month option periods, with a total estimated value of $30.3 billion. The contract aims to establish Prime Vendor Contracts for the PPV-G program, which provides worldwide pharmaceutical support to the Defense Health Agency (DHA), Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet, including the Hospital Ships USNS Mercy and USNS Comfort. The contract covers a comprehensive range of pharmaceutical products, including brand-name, generic, and specialty medications, as well as related medical supplies such as syringes, vials, and test kits, across multiple therapeutic areas. The contract is an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation, with the potential for a reverse auction to obtain the best distribution fees for the primary supplier(s).

The original solicitation was for a pre-solicitation announcement, indicating the DLA Troop Support Medical Supply Chain's intention to issue a solicitation for the PPV-G GEN V program. The solicitation is expected to be issued in March 2024 and remain open for 45 days, with a vendor pre-proposal conference scheduled prior to the closing date. The contract will have a 30-month base period and three 30-month option periods, with the intention to make multiple awards for separate regions, including North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet (CONUS/OCONUS), as well as a separate award for a back-up supplier.